1. Pittas AG, Lau j, Hu FB, Dawson‑Huges B. The role of vitamin 
D and calcium in type 2 diabetes. A systematic review and 
meta‑analysis. J Clin Endocrinol Metab 2007;92:2017‑29.
2. KumarS, DaviesM, ZakariaY, MawerEB,GordonC,OlukogaAO,
et al. Improvement in glucose tolerance and beta‑cell function 
in a patient with vitamin D deficiency during treatment with 
vitamin D. Postgrad Med J 1994;70:440‑3.
3. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is 
associated with insulin resistance and B cell dysfunction. Am 
J Clin Nutr 2004;79:820‑5.
4. Schwolfenberg G. Vitamin D and diabetes: improvement 
of glycemic control with vitamin D3 repletion. Can Fam 
Physician 2008;54:864‑6.
5. Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, 
Deluca HF. Cellular mechanisms of insulin release: the effects 
of vitamin D deficiency and repletion on rat insulin secretion. 
Endocrinology 1983;113:1511‑8.
6. Code C, NormanAW. Vitamin D3 improves impaired glucose 
tolerance and insulin secretion in the vitamin D‑deficient rat 
in vivo. Endocrinology 1986;119:84‑90.
7. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, 
Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle 
intervention to prevent or delay type 2 diabetes in people 
with impaired glucose tolerance: Systematic review and 
meta‑analysis. BMJ 2007;334:299.
8. Vaccaro O, Riccardi G. Changing the definition of impaired 
fasting glucose: Impact on the classification of individuals and 
risk definition. Diabetes Care 2005;28:1786‑8.
9. Abdelmannan D, Tahboub R, Genuth S, Ismail‑Beigi F. Effect 
of dexamethasone on oral glucose tolerance in healthy adults. 
Endocr Pract 2010;16:770‑7.
10. HolickMF. Vitamin D deficiency. N Engl J Med 2007;357:266‑81.
11. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol 
Metab 2010;95:471‑8.
12. Ozfirat Z, Choudhury TA. Vitamin D deficiency and type 2 
diabetes. Postgrad Med J 2010;86:18‑25.
13. Mattila C, Knekt P, Männistö S, Rissanen H, Laaksonen MA, 
Montonen J, et al. Serum 25‑hydroxy vitamin D concentration 
and subsequent risk of type 2 diabetes. Diabetes Care 
2007;30:2569‑70.
14. Li C, Ford ES, Zhao G, MokdadAH. Prevalence of pre‑diabetes 
and its association with clustering of cardiometabolic risk 
factors and hyperinsulinemia among U.S. adolescents: 
National Health and Nutrition Examination Survey 2005‑2006. 
Diabetes Care 2009;32:342‑7.
15. Schwalfenberg G. Vitamin D and diabetes: improvement 
of glycemic control with vitamin D3 repletion. Can Fam 
Physician 2008;54:864‑6.
16. Fonseca VA. Identification and treatment of predibetes to 
prevent progression to type 2 diabetes. Clinic Cornerstone 
2008;9:51‑9.
17. Hyppönen E, BoucherBJ, BerryDJ, PowerC. 25‑hydroxyvitamin 
D, IGF‑1, and metabolic syndrome at 45 years of age: A 
cross‑sectional study in the 1958 British Birth Cohort. Diabetes 
2008;57:298‑305.
18. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ. 
Glucose intolerance and impairment of insulin secretion 
in relation to vitamin D deficiency in east London Asians. 
Diabetologia 1995;38:1239‑45.
19. Mattila C, Knekt P, Männistö S, Rissanen H, Laaksonen MA, 
Montonen J, et al. Serum 25‑hydroxyvitamin D concentration 
and subsequent risk of type 2 diabetes. Diabetes Care 
2007;30:2569‑70.
20. de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, 
Kestenbaum B, et al. Calcium plus vitamin D supplementation 
and the risk of incident diabetes in the Women’s Health 
Initiative. Diabetes Care 2008;31:701‑7.
21. Nagpal J, Pande JN, Bhartia A. A double‑blind, randomized, 
placebo‑controlled trial of the short‑term effect of vitamin 
D3 supplementation on insulin sensitivity in apparently 
healthy, middle‑aged, centrally obese men. Diabet Med 
2009;26:19‑27.
22. Nilas L, Christianson C. Treatment with vitamin D or its 
analogues does not change body weight or blood glucose level 
in postmenopausal women. Int J Obes 1984;8:407‑11.
23. Taylor AV, Wise PH. Vitamin D replacement in Asians with 
diabetes may increase insulin resistance. Postgrad Med J 
1998;74:365‑6.